Comparison of the effectiveness of risperidone and aripiprazole in controlling aggression in inpatient adolescents with conduct disorder
Phase 3
Recruiting
- Conditions
- Conduct disorder.Conduct disorders
- Registration Number
- IRCT20210718051932N1
- Lead Sponsor
- niversity of social welfare and rehabilitation sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 62
Inclusion Criteria
Conduct disorder by criteria DSM5
Age 10-12 years old
Patient admitted to the psychiatric ward
Exclusion Criteria
Bipolar disorder
Suicidal idea
Psychotic disorder
Drug allergy to risperidon or aripiprazol
Severe medical problems
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Aggression. Timepoint: At the end of 1, 2, 4, 6 weeks,. Method of measurement: Bass and Perry Clinical Global Impression scale (CGI).
- Secondary Outcome Measures
Name Time Method